Sigma Labs receives contract for next-generation munitions development
Sigma Labs, Inc. announced today it was awarded a new munitions development contract from the US Department of Defense that seeks new, lighter weight, munitions solutions capable of more energy on target and reduced collateral damage.
Mr. Richard Mah, CEO of Sigma Labs, Inc., stated that: "Current munitions are 30 percent high explosive and 70 percent steel, or extra weight being carried around that releases no energy. This steel often ends up as shrapnel and causes unintended casualties. We believe that our patent-pending technology will turn this ratio on its head - allowing weapons to carry twice as much energetic material for every pound of weapon delivered, or to pack the same explosive punch in a much smaller weapon. It will also enable a new class of 21st Century munitions for precision delivery."
Sigma Labs, Inc. is working with a commercialization partner, one of the largest munitions producers in the United States. Mr. Mark Cola, President of Sigma Labs, Inc., believes that: "The close working relationship we have with our commercialization partner could enable more rapid deployment of this technology to the defense market and greater participation in current or future weapons programs of record."
Source: Sigma Labs
More from Land Warfare
-
Germany and UK to work on Deep Precision Strike weapon
The weapon will have a range of more than 2,000km, according to the UK Ministry of Defence.
-
Netherlands bolsters armed forces with Leopard tanks and Puma UAS fleet upgrades
The procurement announcements emphasise the Dutch Ministry of Defence’s response to NATO’s call for heavier combat capabilities for land operations.
-
BAE Systems expands Amphibious Combat Vehicle family with modular capabilities for future missions
BAE Systems recently announced two contracts for a total of 60 ACVs for the US Marines and has displayed its ACV Logistics concept.
-
Lockheed Martin builds first Saudi Arabian THAAD components
The THAAD launcher was first procured by Saudi Arabia in 2017, with local production a key condition of the sale.